{"id":82577,"date":"2024-07-29T18:59:18","date_gmt":"2024-07-29T18:59:18","guid":{"rendered":"https:\/\/neclink.com\/index.php\/2024\/07\/29\/guardant-healths-stock-up-after-fda-approves-its-blood-test-for-colon-cancer-screening\/"},"modified":"2024-07-29T18:59:18","modified_gmt":"2024-07-29T18:59:18","slug":"guardant-healths-stock-up-after-fda-approves-its-blood-test-for-colon-cancer-screening","status":"publish","type":"post","link":"https:\/\/neclink.com\/index.php\/2024\/07\/29\/guardant-healths-stock-up-after-fda-approves-its-blood-test-for-colon-cancer-screening\/","title":{"rendered":"Guardant Health\u2019s stock up after FDA approves its blood test for colon-cancer screening"},"content":{"rendered":"<p> <br \/>\n<br \/><img decoding=\"async\" src=\"https:\/\/images.mktw.net\/im-33634183\" \/><br \/>It\u2019s the first such blood test to receive regulatory approval in the U.S. and the first that meets the requirements for Medicare coverage.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.marketwatch.com\/story\/guardant-healths-stock-up-after-fda-approves-its-blood-test-for-colon-cancer-screening-ec99ab66?mod=mw_rss_topstories\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>It\u2019s the first such blood test to receive regulatory approval in the U.S. and the first that meets the requirements for Medicare coverage. Source link<\/p>\n","protected":false},"author":1,"featured_media":82578,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[163],"tags":[],"class_list":["post-82577","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/posts\/82577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/comments?post=82577"}],"version-history":[{"count":0,"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/posts\/82577\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/media\/82578"}],"wp:attachment":[{"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/media?parent=82577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/categories?post=82577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neclink.com\/index.php\/wp-json\/wp\/v2\/tags?post=82577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}